Clinical outcome and humoral immune responses of β-thalassemia major patients with severe iron overload to SARS-CoV-2 infection and vaccination: a prospective cohort studyResearch in context
Summary: Background: COVID-19 has raised special concern for patients with β-thalassemia major (β-TM) due to frequent comorbidities, regular blood transfusions, and iron overload. However, the exact implications of COVID-19 for patients with β-TM remain uncertain. We aimed to explore the COVID-19 i...
Main Authors: | Hussam Ghoti, Hala Zreid, Israa Ghoti, Arno R. Bourgonje, Arjan Diepstra, Harry van Goor, Irit Avivi, Hisham Jeadi, Larissa E. van Eijk, Günter Weiss |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2023-08-01
|
Series: | EClinicalMedicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2589537023002730 |
Similar Items
-
A National Registry of Thalassemia in Turkey: Demographic and Disease Characteristics of Patients, Achievements, and Challenges in Prevention
by: Yeşim Aydınok, et al.
Published: (2018-02-01) -
Splenectomy: Does it help in Patients with Thalassemia Major
by: Abdul Salam Memon, et al.
Published: (2017-03-01) -
Splenic abscess in Beta-Thalassemia Major: a case report
by: Rushita Makadia, et al.
Published: (2023-04-01) -
Management of Iron Overload in Beta-Thalassemia Patients: Clinical Practice Update Based on Case Series
by: Valeria Maria Pinto, et al.
Published: (2020-11-01) -
Assessment of iron chelation therapy adherence in patients with thalassemia major in Babylon Province
by: Mohammed Ali Al-Jabory, et al.
Published: (2023-01-01)